
51 - 200 employees
Founded 2018
🧬 Biotechnology
🏥 Healthcare
đź’Š Pharmaceuticals
🔥 Funding within the last year
đź’° $300M Post-IPO Equity on 2026-07
Biotechnology • Healthcare • Pharmaceuticals
Dyne Therapeutics is a clinical-stage biotechnology company developing therapies for genetically driven neuromuscular diseases. Using its proprietary FORCE™ platform, Dyne designs precision therapeutics aimed at addressing the root causes of conditions such as Duchenne muscular dystrophy (DMD), myotonic dystrophy type 1 (DM1), and facioscapulohumeral muscular dystrophy (FSHD). The company maintains an active clinical pipeline (including assets named Zeleciment rostudirsen/DYNE-251, Zeleciment basivarsen/DYNE-101, and DYNE-302), runs clinical trials, and emphasizes patient-centered development and community engagement.
📡 We watch Dyne Therapeutics's careers page
Every 2 hours
how often we check
2
roles posted in the last 30 days
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 1 hour ago
Director leading clinical and regulatory medical writing for Dyne Therapeutics’ neuromuscular disease therapies. Driving FDA and global health authority submissions across cross-functional development programs.
🍂 Massachusetts – Remote
đź’µ $190k - $235k / year
🔥 Funding within the last year
đź’° $300M Post-IPO Equity on 2026-07
⏰ Full Time
đź”´ Lead
👨‍⚕️ Medical Director
đź‘» Ghost score 0%
🔥 1 hour ago
Medical writing director leading clinical and regulatory submissions for Dyne Therapeutics’ neuromuscular disease programs. Driving document strategy, authoring, review, and cross-functional alignment.
🍂 Massachusetts – Remote
đź’µ $190k - $235k / year
🔥 Funding within the last year
đź’° $300M Post-IPO Equity on 2026-07
⏰ Full Time
đź”´ Lead
👨‍⚕️ Medical Director
đź‘» Ghost score 0%